NovoCure Limited Ordinary Shares
NVCR Real Time Price USDRecent trades of NVCR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in NVCR holdings by institutional investors
Quarterly net insider trading by NVCR's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$110,000 Oct 13, 2025 Issue: Medicare/Medicaid
-
$110,000 Jul 15, 2025 Issue: Medicare/Medicaid Veterans
-
$110,000 Apr 16, 2025 Issue: Medicare/Medicaid Veterans
-
$110,000 Jan 14, 2025 Issue: Medicare/Medicaid Veterans
-
$120,000 Oct 15, 2024 Issue: Veterans Medicare/Medicaid
-
$220,000 Jul 22, 2024 Issue: Veterans Medicare/Medicaid
-
$200,000 Apr 22, 2024 Issue: Veterans Medicare/Medicaid
-
$140,000 Oct 19, 2023 Issue: Medicare/Medicaid
-
$180,000 Aug 02, 2023 Issue: Transportation Veterans Medicare/Medicaid
-
$120,000 Feb 18, 2023 Issue: Transportation Veterans Medicare/Medicaid
-
$120,000 Oct 16, 2022 Issue: Veterans Medicare/Medicaid
-
$120,000 Jul 20, 2022 Issue: Veterans Medicare/Medicaid
-
$110,000 Apr 20, 2022 Issue: Medicare/Medicaid
-
$80,000 Jan 19, 2022 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
-
$150,000 Oct 20, 2021 Issue: Health Issues
-
$20,000 Oct 19, 2021 Issue: Budget/Appropriations Medicare/Medicaid Health Issues
-
$100,000 Jul 20, 2021 Issue: Health Issues
-
$90,000 Apr 20, 2021 Issue: Health Issues
-
$100,000 Jan 18, 2021 Issue: Health Issues
-
$100,000 Oct 18, 2020 Issue: Science/Technology Medical/Disease Research/Clinical Labs Insurance Copyright/Patent/Trademark Health Issues Manufacturing Veterans Medicare/Medicaid Budget/Appropriations
-
$110,000 Jul 20, 2020 Issue: Science/Technology Health Issues Copyright/Patent/Trademark Manufacturing Veterans Medicare/Medicaid Budget/Appropriations Insurance Medical/Disease Research/Clinical Labs
-
$110,000 Apr 20, 2020 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Veterans Health Issues Copyright/Patent/Trademark Insurance Manufacturing Medicare/Medicaid Science/Technology
-
$180,000 Jan 20, 2020 Issue: Science/Technology Insurance Budget/Appropriations Veterans Health Issues Copyright/Patent/Trademark Manufacturing Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$140,000 Oct 21, 2019 Issue: Insurance Medicare/Medicaid Veterans Copyright/Patent/Trademark Manufacturing Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs Science/Technology
-
$120,000 Jul 22, 2019 Issue: Medical/Disease Research/Clinical Labs Budget/Appropriations Manufacturing Copyright/Patent/Trademark Health Issues Veterans Medicare/Medicaid Insurance Science/Technology
-
$90,000 Apr 22, 2019 Issue: Health Issues
-
$90,000 Jan 22, 2019 Issue: Health Issues
-
$80,000 Oct 22, 2018 Issue: Health Issues
-
$80,000 Jul 19, 2018 Issue: Health Issues
-
$80,000 Apr 20, 2018 Issue: Health Issues
-
$28,000 Jan 22, 2018 Issue: Health Issues
-
$60,000 Jan 19, 2018 Issue: Health Issues
-
$84,000 Oct 20, 2017 Issue: Health Issues
-
$80,000 Jul 13, 2017 Issue: Health Issues
-
$80,000 Apr 19, 2017 Issue: Health Issues
-
$110,000 Jan 23, 2017 Issue: Health Issues
-
$50,000 Oct 20, 2016 Issue: Health Issues
-
$111,000 Jul 20, 2016 Issue: Health Issues
-
$50,000 Apr 20, 2016 Issue: Health Issues
-
$110,000 Jan 18, 2016 Issue: Health Issues
-
$50,000 Oct 20, 2015 Issue: Health Issues
-
$100,000 Jul 20, 2015 Issue: Health Issues
-
$60,000 Apr 20, 2015 Issue: Government Issues Medicare/Medicaid Health Issues
-
$40,000 Apr 15, 2015 Issue: Health Issues
-
$60,000 Jan 20, 2015 Issue: Health Issues
-
$10,000 Jan 20, 2015 Issue: Government Issues Medicare/Medicaid Health Issues
-
$60,000 Oct 20, 2014 Issue: Health Issues
-
$140,000 Oct 17, 2014 Issue: Government Issues Medicare/Medicaid Health Issues
-
$10,000 Jul 21, 2014 Issue: Health Issues
-
$130,000 Jul 21, 2014 Issue: Government Issues Health Issues Medicare/Medicaid
-
$30,000 Jul 21, 2014 Issue: Government Issues Medicare/Medicaid Health Issues
-
$30,000 Jul 21, 2014 Issue: Medicare/Medicaid Government Issues Health Issues
NVCR Estimated quarterly lobbying spending
NVCR Revenue by Segment or Geography
New NVCR patent grants
-
Patent Title: Transducer array flexibility and methods of production and use thereof Nov. 18, 2025
-
Patent Title: Methods, systems, and apparatuses for associating dielectric properties with a patient model Nov. 18, 2025
-
Patent Title: Adjusting tumor treating fields simulation and treatment using molecular imaging Nov. 11, 2025
-
Patent Title: Pad generating tumor treating field and having kirigami-like cuts Nov. 11, 2025
-
Patent Title: Devices, systems, and methods for removing and replacing a subassembly of an electrode assembly Nov. 11, 2025
-
Patent Title: Medical treatment device Nov. 04, 2025
-
Patent Title: Compositions and methods for imaging a cell Nov. 04, 2025
-
Patent Title: Methods of treating disease by skewing macrophage phenotype with alternating electric fields Oct. 14, 2025
-
Patent Title: Electrode array Jun. 03, 2025
-
Patent Title: Electrode array Jun. 03, 2025
-
Patent Title: Electrode array May. 27, 2025
-
Patent Title: Electrode array May. 27, 2025
-
Patent Title: Electrode array May. 27, 2025
-
Patent Title: Animal cage Jan. 14, 2025
-
Patent Title: Electrode array Dec. 31, 2024
-
Patent Title: Electrode array Dec. 31, 2024
-
Patent Title: Electrode array Dec. 24, 2024
-
Patent Title: Carrying case Sep. 17, 2024
-
Patent Title: Medical treatment device Aug. 20, 2024
-
Patent Title: Electrode array Jan. 02, 2024
-
Patent Title: Electrode array Jan. 02, 2024
-
Patent Title: Electrode array Jan. 02, 2024
-
Patent Title: Electrode array Jan. 02, 2024
-
Patent Title: Electrode array Dec. 26, 2023
-
Patent Title: Electrode array Aug. 09, 2022
-
Patent Title: Electrode array Aug. 02, 2022
-
Patent Title: Display screen or portion thereof with a graphical user interface Nov. 02, 2021
-
Patent Title: High voltage, high efficiency sine wave generator with pre-set frequency and adjustable amplitude Mar. 06, 2018
-
Patent Title: Treating bacteria with electric fields Sep. 05, 2017
-
Patent Title: Optimizing treatment using ttfields by changing the frequency during the course of long term tumor treatment May. 23, 2017
-
Patent Title: Treating bacteria with electric fields Sep. 13, 2016
-
Patent Title: Treating bacteria with electric fields Jun. 16, 2015
-
Patent Title: Treating bacteria with electric fields May. 26, 2015
-
Patent Title: Treating cancer using electromagnetic fields in combination with photodynamic therapy May. 05, 2015
-
Patent Title: Treating cancer using electromagnetic fields in combination with photodynamic therapy May. 05, 2015
-
Patent Title: Composite electrode Jul. 01, 2014
-
Patent Title: Optimizing characteristics of an electric field to increase the field's effect on proliferating cells May. 06, 2014
-
Patent Title: Composite electrode May. 06, 2014
-
Patent Title: Treating a tumor or the like with electric fields at different frequencies Apr. 22, 2014
-
Patent Title: Treating cancer using electromagnetic fields in combination with photodynamic therapy Jun. 18, 2013
-
Patent Title: Treating bacteria with electric fields May. 21, 2013
-
Patent Title: Treating bacteria with electric fields May. 21, 2013
-
Patent Title: Treating cancer using electromagnetic fields in combination with other treatment regimens Mar. 26, 2013
-
Patent Title: Method and apparatus for destroying dividing cells Aug. 28, 2012
-
Patent Title: Treating a tumor or the like with electric fields at different frequencies Aug. 14, 2012
-
Patent Title: Probe for treating a tumor or the like Jul. 24, 2012
-
Patent Title: Treating bacteria with electric fields May. 08, 2012
-
Patent Title: Electrodes for applying an electric field in-vivo over an extended period of time May. 01, 2012
-
Patent Title: Treating cancer using electromagnetic fields in combination with other treatment regimens Sep. 13, 2011
-
Patent Title: Treating parasites with electric fields Feb. 15, 2011
Federal grants, loans, and purchases
- $49,749 2025-09-24 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-09-23 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-09-23 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-09-22 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-09-15 00:00:00 Agency: Department of Veterans Affairs
- $45,600 2025-09-09 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-09-05 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-09-04 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-09-03 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-09-03 00:00:00 Agency: Department of Veterans Affairs
- $99,497 2025-08-29 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-28 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-08-27 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-08-25 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-22 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-21 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-08-19 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-19 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-14 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-08-14 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-08-12 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-12 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-11 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-11 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-11 00:00:00 Agency: Department of Veterans Affairs
- $99,497 2025-08-11 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-08 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-08 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-08-07 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-07 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-07 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-04 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-08-04 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-31 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-31 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-30 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-30 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-07-24 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-24 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-23 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-07-22 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-18 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-18 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-15 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-15 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-15 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-11 00:00:00 Agency: Department of Veterans Affairs
- $16,583 2025-07-09 00:00:00 Agency: Department of Veterans Affairs
- $49,749 2025-07-08 00:00:00 Agency: Department of Veterans Affairs
- $66,332 2025-07-06 00:00:00 Agency: Department of Veterans Affairs
Estimated quarterly amount awarded to NVCR from public contracts
Recent insights relating to NVCR
Recent picks made for NVCR stock on CNBC
ETFs with the largest estimated holdings in NVCR
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $NVCR stock a Buy, Sell, or Hold?
- What is the price target for $NVCR stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $NVCR stock?
- Who owns the most shares of $NVCR stock?
- What funds own $NVCR stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NVCR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.